News Duchenne drug available in England within weeks after NICE a... NHS England struck deal speeding access to drug.
News Scotland's Opdivo decision sparks funding row Patients in Scotland will receive lung cancer drug, those in England will not.
News Patients denied thyroid cancer drug in England Eisai considers legal action over funding "black hole".
News Pfizer leukaemia drug accepted by NICE Bosulif is first drug to be funded following reassessment.
News Hengrui gets world-first okay for platelet drug hetrombopag Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
